I
0.360
0.02 (5.85%)
| Penutupan Terdahulu | 0.340 |
| Buka | 0.340 |
| Jumlah Dagangan | 445,602 |
| Purata Dagangan (3B) | 7,680,163 |
| Modal Pasaran | 16,470,859 |
| Harga / Jualan (P/S) | 0.650 |
| Harga / Buku (P/B) | 0.990 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Mar 2025 |
| Margin Keuntungan | -115.93% |
| Margin Operasi (TTM) | -46.38% |
| EPS Cair (TTM) | -1.17 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -0.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 50.26% |
| Nisbah Semasa (MRQ) | 1.01 |
| Aliran Tunai Operasi (OCF TTM) | -7.74 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -2.71 M |
| Pulangan Atas Aset (ROA TTM) | -13.68% |
| Pulangan Atas Ekuiti (ROE TTM) | -65.88% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | ImmunoPrecise Antibodies Ltd. | Menurun | Menurun |
AISkor Stockmoo
1.0
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 1.00 |
|
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 5.27% |
| % Dimiliki oleh Institusi | 4.17% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Cibc World Market Inc. | 31 Dec 2024 | 41,200 |
| Gradient Capital Advisors, Llc | 31 Dec 2024 | 26,808 |
| Rathbones Group Plc | 31 Dec 2024 | 14,000 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 5.00 (HC Wainwright & Co., 1,289.28%) | Beli |
| Median | 4.00 (1,011.42%) | |
| Rendah | 3.00 (Benchmark, 733.57%) | Tidak Dinilai |
| Purata | 4.00 (1,011.42%) | |
| Jumlah | 1 Beli, 1 Tidak Dinilai | |
| Harga Purata @ Panggilan | 0.369 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Benchmark | 01 Apr 2025 | 3.00 (733.56%) | Tidak Dinilai | 0.361 |
| HC Wainwright & Co. | 31 Mar 2025 | 5.00 (1,289.27%) | Beli | 0.377 |
| 14 Mar 2025 | 7.00 (1,844.98%) | Beli | 0.385 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |